These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15155547)
1. Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. Hidaka M; Fujita K; Ogikubo T; Yamasaki K; Iwakiri T; Okumura M; Kodama H; Arimori K Drug Metab Dispos; 2004 Jun; 32(6):581-3. PubMed ID: 15155547 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of citrus fruits on cytochrome P450 3A (CYP3A) activity in humans. Fujita K; Hidaka M; Takamura N; Yamasaki K; Iwakiri T; Okumura M; Kodama H; Yamaguchi M; Ikenoue T; Arimori K Biol Pharm Bull; 2003 Sep; 26(9):1371-3. PubMed ID: 12951492 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of fruit juices on CYP3A activity. Kim H; Yoon YJ; Shon JH; Cha IJ; Shin JG; Liu KH Drug Metab Dispos; 2006 Apr; 34(4):521-3. PubMed ID: 16415112 [TBL] [Abstract][Full Text] [Related]
4. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Guo LQ; Fukuda K; Ohta T; Yamazoe Y Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150 [TBL] [Abstract][Full Text] [Related]
5. Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Hidaka M; Okumura M; Fujita K; Ogikubo T; Yamasaki K; Iwakiri T; Setoguchi N; Arimori K Drug Metab Dispos; 2005 May; 33(5):644-8. PubMed ID: 15673597 [TBL] [Abstract][Full Text] [Related]
6. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice. Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222 [TBL] [Abstract][Full Text] [Related]
7. Transient inhibition of cyp3a in rats by star fruit juice. Hidaka M; Okumura M; Ogikubo T; Kai H; Fujita K; Iwakiri T; Yamasaki K; Setoguchi N; Matsunaga N; Arimori K Drug Metab Dispos; 2006 Mar; 34(3):343-5. PubMed ID: 16326816 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of fruit juices on cytochrome P450 2C9 activity in vitro. Hidaka M; Nagata M; Kawano Y; Sekiya H; Kai H; Yamasaki K; Okumura M; Arimori K Biosci Biotechnol Biochem; 2008 Feb; 72(2):406-11. PubMed ID: 18256496 [TBL] [Abstract][Full Text] [Related]
9. Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice. Farkas D; Oleson LE; Zhao Y; Harmatz JS; Zinny MA; Court MH; Greenblatt DJ J Clin Pharmacol; 2007 Mar; 47(3):286-94. PubMed ID: 17322140 [TBL] [Abstract][Full Text] [Related]
10. Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. Nagata M; Hidaka M; Sekiya H; Kawano Y; Yamasaki K; Okumura M; Arimori K Drug Metab Dispos; 2007 Feb; 35(2):302-5. PubMed ID: 17132763 [TBL] [Abstract][Full Text] [Related]
11. Grapefruit juice intake does not enhance but rather protects against aflatoxin B1-induced liver DNA damage through a reduction in hepatic CYP3A activity. Miyata M; Takano H; Guo LQ; Nagata K; Yamazoe Y Carcinogenesis; 2004 Feb; 25(2):203-9. PubMed ID: 14578159 [TBL] [Abstract][Full Text] [Related]
12. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis. Kharasch ED; Walker A; Hoffer C; Sheffels P Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of methoxymorpholinyl doxorubicin: potentiation by cytochrome P450 3A metabolism. Lu H; Waxman DJ Mol Pharmacol; 2005 Jan; 67(1):212-9. PubMed ID: 15465924 [TBL] [Abstract][Full Text] [Related]
14. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Edwards DJ; Bellevue FH; Woster PM Drug Metab Dispos; 1996 Dec; 24(12):1287-90. PubMed ID: 8971132 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Guo LQ; Taniguchi M; Xiao YQ; Baba K; Ohta T; Yamazoe Y Jpn J Pharmacol; 2000 Feb; 82(2):122-9. PubMed ID: 10877530 [TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of CYP3A by HIV protease inhibitors. Ernest CS; Hall SD; Jones DR J Pharmacol Exp Ther; 2005 Feb; 312(2):583-91. PubMed ID: 15523003 [TBL] [Abstract][Full Text] [Related]
17. Drug interaction potentials among different brands of grapefruit juice. Uesawa Y; Mohri K Pharmazie; 2008 Feb; 63(2):144-6. PubMed ID: 18380401 [TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes. Zhu M; Zhao W; Jimenez H; Zhang D; Yeola S; Dai R; Vachharajani N; Mitroka J Drug Metab Dispos; 2005 Apr; 33(4):500-7. PubMed ID: 15640381 [TBL] [Abstract][Full Text] [Related]
19. Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans. Kanazu T; Yamaguchi Y; Okamura N; Baba T; Koike M Xenobiotica; 2004 May; 34(5):391-402. PubMed ID: 15370956 [TBL] [Abstract][Full Text] [Related]
20. Use of a benzyloxy-substituted lactone cyclooxygenase-2 inhibitor as a selective fluorescent probe for CYP3A activity in primary cultured rat and human hepatocytes. Nicoll-Griffith DA; Chauret N; Houle R; Day SH; D'Antoni M; Silva JM Drug Metab Dispos; 2004 Dec; 32(12):1509-15. PubMed ID: 15550722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]